BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25605145)

  • 1. RNAi-based knockdown of multidrug resistance-associated protein 1 is sufficient to reverse multidrug resistance of human lung cells.
    Shao SL; Cui TT; Zhao W; Zhang WW; Xie ZL; Wang CH; Jia HS; Liu Q
    Asian Pac J Cancer Prev; 2014; 15(24):10597-601. PubMed ID: 25605145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect and mechanism of microRNA-21 on cis-dichlorodiamineplatinum resistance in lung cancer cell strain].
    Ren L; Huang C; Liu YH; Yu Y; Lin L; Wen LJ
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1454-8. PubMed ID: 27266356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. siRNA silencing EZH2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells.
    Zhou W; Wang J; Man WY; Zhang QW; Xu WG
    Asian Pac J Cancer Prev; 2015; 16(6):2425-30. PubMed ID: 25824776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
    Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J
    Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA916798 regulates multidrug resistance of lung cancer cells.
    Wang HJ; Yang HP; Zhou XD; Dai XT; Chen YF; Xiong W
    Asian Pac J Cancer Prev; 2011; 12(12):3403-8. PubMed ID: 22471488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1.
    Wang TH; Wan JY; Gong X; Li HZ; Cheng Y
    Oncol Rep; 2012 Nov; 28(5):1681-6. PubMed ID: 22941407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.
    Xu P; Jiang YF; Wang JH
    Int J Clin Exp Pathol; 2015; 8(3):2300-10. PubMed ID: 26045737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased ABCC2 expression predicts cisplatin resistance in non-small cell lung cancer.
    Chen Y; Zhou H; Yang S; Su D
    Cell Biochem Funct; 2021 Mar; 39(2):277-286. PubMed ID: 32815556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stephania Tetrandra and Ginseng-Containing Chinese Herbal Formulation NSENL Reverses Cisplatin Resistance in Lung Cancer Xenografts.
    Jin L; Xu M; Luo XH; Zhu XF
    Am J Chin Med; 2017; 45(2):385-401. PubMed ID: 28231742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway.
    Wang H; Jia XH; Chen JR; Yi YJ; Wang JY; Li YJ; Xie SY
    Int J Oncol; 2016 Dec; 49(6):2529-2537. PubMed ID: 27779650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversing effect and mechanism of soluble resistance-related calcium-binding protein on multidrug resistance in human lung cancer A549/DDP cells.
    Gao Y; Li W; Liu X; Gao F; Zhao X
    Mol Med Rep; 2015 Mar; 11(3):2118-24. PubMed ID: 25394367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reverse effect of genetically modified adenovirus H101 on drug-resistance of A549/DDP cells to cisplatin].
    Xu RH; Yuan ZY; Guan ZZ; Li S
    Ai Zheng; 2005 Aug; 24(8):975-9. PubMed ID: 16086876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma A549/DDP cell to cisplatin and diallyl disulfide.
    Huang Z; Lei X; Zhong M; Zhu B; Tang S; Liao D
    Acta Biochim Biophys Sin (Shanghai); 2007 Nov; 39(11):835-43. PubMed ID: 17989874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of MDR1 gene-dependent multidrug resistance in HL60/HT9 cells using short hairpin RNA expression vectors.
    Shao SL; Zhang WW; Li XY; Zhang ZZ; Yun DZ; Fu B; Zuo MX
    Cancer Biother Radiopharm; 2010 Apr; 25(2):171-7. PubMed ID: 20423230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear translocation of MRP1 contributes to multidrug resistance of mucoepidermoid carcinoma.
    Cai BL; Xu XF; Fu SM; Shen LL; Zhang J; Guan SM; Wu JZ
    Oral Oncol; 2011 Dec; 47(12):1134-40. PubMed ID: 21903448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells.
    Yu G; Zhong N; Chen G; Huang B; Wu S
    Tumour Biol; 2014 Oct; 35(10):10341-9. PubMed ID: 25038915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non‑coding RNA AK001796 contributes to cisplatin resistance of non‑small cell lung cancer.
    Liu B; Pan CF; Ma T; Wang J; Yao GL; Wei K; Chen YJ
    Mol Med Rep; 2017 Oct; 16(4):4107-4112. PubMed ID: 29067469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of Topo II alpha gene expression and reversing of drug resistance in multi-drug resistant epithelial ovarian cancer cells induced by RNA interference in vitro].
    He J; Li L; Tang BJ; Zhang W; Li DR; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):686-90. PubMed ID: 20079182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA DANCR accelerates the development of multidrug resistance of gastric cancer.
    Xu YD; Shang J; Li M; Zhang YY
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2794-2802. PubMed ID: 31002130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.